SBIR vs STTR: Which Program Is Right for Your Company

If you've been exploring federal funding for your research and development work, you've almost certainly encountered two acronyms that appear side by side: SBIR and STTR. Both programs channel billions of dollars to small businesses each year, both offer non-dilutive funding that doesn't require you to give up equity, and both are administered by the Small Business Administration across eleven participating federal agencies. But they are not the same program, and choosing the wrong one can cost you time, money, and competitive advantage.

This guide breaks down the real differences between SBIR and STTR, helps you assess which fits your situation, and gives you a clear path forward for 2026 funding cycles.

The Core Difference: What Each Program Actually Requires

The Small Business Innovation Research program is designed for small businesses that want to conduct R&D using their own internal capabilities. You hire your scientists, engineers, and researchers as employees or consultants, you own the work, and the federal government evaluates your company's ability to commercialize the resulting technology.

The Small Business Technology Transfer program introduces a structural requirement that changes the entire equation: you must partner with a nonprofit research institution. That means a university, a federally funded research and development center, or a nonprofit research organization must be formally involved in the project. The research institution is not a subcontractor in name only — STTR mandates that at least 30 percent of the federal award goes directly to your research partner.

This single distinction drives most of the practical differences between the two programs.

Eligibility: Where the Programs Diverge

Both SBIR and STTR require your company to be a for-profit small business with 500 or fewer employees, majority-owned by U.S. citizens or permanent residents, and organized as a U.S. entity. Beyond that baseline, the requirements split.

For SBIR, the principal investigator — the person leading the research — must be primarily employed by your small business at the time of award and throughout most of the project period. This means the lead researcher needs to spend the majority of their working time at your company, not at a university or research lab.

STTR removes that restriction entirely. Your principal investigator can be employed by the research institution partner rather than by your company. This makes STTR an appealing route when the core scientific expertise lives inside a university and you want to commercialize discoveries coming out of academic labs.

Intellectual Property and Licensing

One area where companies sometimes get surprised is intellectual property. SBIR awards generally give your small business strong IP protections, with the government retaining a license for its own use but your company holding the rights to commercialize.

STTR requires a formal written agreement between your company and your research partner that specifies IP rights, licensing terms, and commercialization responsibilities before the award is made. Negotiating this agreement takes time and legal counsel, and universities in particular can be protective of their IP. If you're moving quickly, this upfront work is worth factoring into your timeline.

Funding Levels and the Phase Structure

Both programs follow a three-phase structure, though STTR only mandates federal funding in the first two phases.

• Phase I: Feasibility and proof of concept. SBIR awards are typically up to $275,000; STTR awards are typically up to $275,000 as well, though amounts vary by agency.
• Phase II: Full R&D effort and prototype development. Awards commonly range from $750,000 to $1.75 million depending on the agency and topic area.
• Phase III: Commercialization. Federal agencies no longer provide SBIR or STTR funds directly, but awardees can pursue federal contracts and private investment.

Agencies set their own award amounts within these general ranges, and in 2026 several agencies including the Department of Defense and the National Institutes of Health have adjusted their funding levels upward to reflect R&D cost realities. Checking the specific solicitation for your target agency is essential.

How to Choose: A Practical Decision Framework

Rather than treating this as an abstract choice, work through these four questions.

1. Do you have the technical talent in-house? If your company already employs or can hire the scientists and engineers to carry out the proposed research, SBIR is the cleaner path. You maintain full control and avoid the complexity of a formal institutional partnership.

1. Is the core technology sitting inside a university lab? If a professor or research team at a university developed the science you want to commercialize, STTR is often the most natural fit. The program is specifically designed to bridge that gap between academic discovery and market application.

1. How quickly do you need to move? STTR requires you to establish an institutional partnership, negotiate IP terms, and get sign-off from your research partner's sponsored research office before submitting. At universities, this process can take weeks or months. SBIR moves faster when you're working entirely within your own organization.

1. Which agencies fund your technology area? Not every agency participates in both programs. The Department of Defense runs both. The NIH runs both. But some smaller agencies only participate in SBIR. Before committing to STTR, confirm that your target agency has an active STTR solicitation in your technology area.

The Hybrid Approach

Some companies pursue SBIR and STTR awards simultaneously across different projects or different agencies. This is entirely legal and can be a sound strategy if you have distinct R&D tracks — one that relies on internal capabilities and one that leverages a university partnership. Managing multiple federal awards adds administrative overhead, but for companies serious about building an R&D pipeline, the diversification is often worth it.

Getting Your Application Strategy Right in 2026

Federal agencies release solicitations on rolling or twice-yearly schedules. As of late 2026, the Department of Defense has active SBIR and STTR solicitations open, with several agency-specific topics closing in the fourth quarter. NIH releases omnibus solicitations multiple times per year. Understanding the solicitation calendar for your target agencies is the foundation of any effective SBIR or STTR strategy.

Beyond timing, the quality of your application comes down to three things: a clearly articulated commercialization plan, a technically credible approach, and evidence that your team can execute. Reviewers at federal agencies read hundreds of applications. The ones that succeed are specific about the problem being solved, honest about the current state of the technology, and concrete about the path from research to market.

If you're uncertain which program aligns with your company's profile, or if you want to identify which agencies are actively funding your technology area right now, FundFly can help. FundFly's AI matches your company profile to live SBIR and STTR opportunities across all participating agencies, surfaces relevant solicitations before their deadlines, and supports you through the application process. With over one million funding opportunities in the platform, you spend less time searching and more time building. Start your free search on FundFly today and find the program that fits your company.